Abstract
BackgroundAnti-tumour necrosis factor (anti-TNF) biologic therapy is a highly effective yet expensive treatment for patients with Rheumatoid Arthritis (RA). Patient eligibility for therapy and response to treatment is assessed using...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have